The current study showed 3.9-fold decrease in IGF-1 expression in the diabetic group compared to control group, which may be independently associated with obesity, glucose intolerance, diabetes, and atherogenic dyslipidemia [51]. The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.